Cartesian Therapeutics Inc (RNAC)
Cash & Short-Term Investments
$147.61M
Quarterly · Period ending: · USD
RNAC Cash & Short-Term Investments
Latest reported$147.61Mperiod ending
Latest reported$147.61Mperiod ending
RNAC Quarterly Cash & Short-Term Investments ($36.46M → $147.61M)
Quarterly Cash & Short-Term Investments
High-resolution chart · PNG
RNAC cash & short-term investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 147,606,000 | |
| 118,641,000 | |
| 125,139,000 | |
| 143,384,000 | |
| 160,324,000 | |
| 180,434,000 | |
| 212,610,000 | |
| 219,198,000 | |
| 87,227,000 | |
| 103,418,000 | |
| 76,911,000 | |
| 79,603,000 | |
| 112,027,000 | |
| 125,925,000 | |
| 134,602,000 | |
| 146,442,000 | |
| 142,056,000 | |
| 117,434,000 | |
| 128,055,000 | |
| 138,663,000 | |
| 150,138,000 | |
| 147,812,000 | |
| 138,685,000 | |
| 146,261,000 | |
| 59,730,000 | |
| 72,606,000 | |
| 89,893,000 | |
| 34,234,000 | |
| 41,680,000 | |
| 48,417,000 | |
| 37,403,000 | |
| 50,485,000 | |
| 66,228,000 | |
| 83,143,000 | |
| 96,638,000 | |
| 104,388,000 | |
| 112,655,000 | |
| 68,522,000 | |
| 84,141,000 | |
| 79,276,000 | |
| 84,548,000 | |
| 25,979,000 | |
| 36,462,000 |